daratumumab and hyaluronidase-fihj (human recombinant)

FDA Drug Profile — Darzalex Faspro

daratumumab and hyaluronidase-fihj (human recombinant) is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Darzalex Faspro. Available dosage form: injection.

Drug details

Generic Name
daratumumab and hyaluronidase-fihj (human recombinant)
Brand Names
Darzalex Faspro
Application Number
BLA761145
Sponsor
Janssen Biotech, Inc.
NDC Codes
3
Dosage Forms
INJECTION
Routes
SUBCUTANEOUS
Active Ingredients
DARATUMUMAB, HYALURONIDASE (HUMAN RECOMBINANT)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.